Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | GTF2IRD1 |
| Upstream (Parents) |
|---|
| (<<) RPIA → GTF2IRD1 |
| (<<) MYB → GTF2IRD1 |
| (<<) DDR1 → GTF2IRD1 |
| Downstream (Children) |
|---|
| GTF2IRD1 → CNKSR1 (>>) |
| GTF2IRD1 → RPIA (>>) |
| GTF2IRD1 → BCL11B (>>) |
| GTF2IRD1 → PRKAB2 (>>) |
| GTF2IRD1 → SLC26A3 (>>) |
| GTF2IRD1 → CEL (>>) |
| GTF2IRD1 → CELP (>>) |
| GTF2IRD1 → DPEP1 (>>) |
| GTF2IRD1 → KRT23 (>>) |
| GTF2IRD1 → EREG (>>) |
| GTF2IRD1 → EPHB2 (>>) |
| GTF2IRD1 → PTPRO (>>) |
| GTF2IRD1 → EDAR (>>) |
| GTF2IRD1 → MNX1 (>>) |
| GTF2IRD1 → RNF43 (>>) |
| GTF2IRD1 → EFNA3 (>>) |
| GTF2IRD1 → LY75 (>>) |
| GTF2IRD1 → MCF2L (>>) |
| GTF2IRD1 → DDR1 (>>) |
| GTF2IRD1 → JAG2 (>>) |
| GTF2IRD1 → SYS1-DBNDD2///DBNDD2 (>>) |
| GTF2IRD1 → SGPP1 (>>) |
| GTF2IRD1 → SP110 (>>) |
| GTF2IRD1 → ARL4A (>>) |
| GTF2IRD1 → ELF4 (>>) |
| GTF2IRD1 → GBAS (>>) |
| GTF2IRD1 → DGKZ (>>) |
| GTF2IRD1 → MEIS3P1 (>>) |
| GTF2IRD1 → MTUS1 (>>) |
| GTF2IRD1 → ABHD11 (>>) |
| GTF2IRD1 → NSUN5P1 (>>) |
| GTF2IRD1 → TCF7 (>>) |
